Data / Form D filings / Flex Biomedical, Inc.
Flex Biomedical, Inc.: Form D filings
Flex Biomedical, Inc., a pharmaceuticals company in Madison, WI, filed 3 Form D notices with the SEC between 2009 and 2012. The latest, on June 20, 2012, reports $881,668 sold of a $1 million offering to 13 investors.
Find out what Flex Biomedical, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 555 D'ONOFRIO DRIVE, SUITE 102, Madison, WI, 53719
- Phone
- (608) 213-8246
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2007
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1465854
The full lists. Form D filings in Wisconsin: 361 rows, $18.05, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 20, 2012 | New notice | $1,000,000 | $881,668 | $118,332 | 13 | Jun 4, 2012 | sec.gov |
| Nov 3, 2010 | New notice | $694,101 | $694,101 | $0 | 8 | Oct 19, 2010 | sec.gov |
| Jun 15, 2009 | New notice | $1,250,000 | $812,000 | $438,000 | 8 | Jun 10, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Hideki C. Suzuki, PhD | Executive Officer | |
| Salvatore P. Braico | Executive Officer, Director | |
| Nicholas E. Mischler, MD | Director | |
| Mark P. Grinstaff | Director | |
| Donald R. Urbanowicz | Director | |
| David C. Sneider | Director | |
| Steven R. Pollock, RPh, MBA | Director | |
| Michael C. Wathier, PhD | Executive Officer |
Every Form D from the week of Jun 18, 2012 · All recent filings in Wisconsin · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Flex Biomedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.